Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for GT Biopharma Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-11-16
Purchase
2021-10-07
2:47 pm
GT Biopharma Inc. GTBP Wendel Bruce
Director
5,083 $5.1739 $26,299 402,655
(Direct)
View
2020-12-21
Sale
2020-12-23
4:24 pm
GT Biopharma Inc. GTBP Weldon Steven W
Former Officer and Director
183,700 $0.34206 $62,837 3,720,000
(Direct)
View
2020-12-16
Sale
2020-12-18
4:24 pm
GT Biopharma Inc. GTBP Weldon Steven W
Former Officer and Director
200,000 $0.3025 $60,500 3,903,700
(Direct)
View
2020-12-11
Sale
2020-12-15
5:40 pm
GT Biopharma Inc. GTBP Weldon Steven W
Former Officer and Director
396,300 $0.28621 $113,427 4,103,700
(Direct)
View
2020-06-02
Sale
2020-06-04
5:15 pm
GT Biopharma Inc. GTBP Cataldo Tony
CEO
10% Owner
4,234,320 $0.001 $4,234 6,500,000
(Direct)
View
2020-05-13
Sale
2020-05-14
1:40 pm
GT Biopharma Inc. GTBP Weldon Steven W
CFO
2,269,708 $0.001 $2,270 4,500,000
(Direct)
View
2019-02-01
Sale
2019-03-19
2:38 pm
GT Biopharma Inc. GTBP Urbanski Raymond W.
CEO
176,980 $0.001 $177 1,351,918
(Direct)
View
2019-02-06
Sale
2019-02-13
11:22 am
GT Biopharma Inc. GTBP Cataldo Tony
Director
800,000 $0.001 $800 4,029,600
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-02-16
Option Award
2022-02-14
5:10 pm
N/A
2031-02-15
GT Biopharma Inc. GTBP Berk Gregory
Director
328,058 $0 328,058
(Direct)
View
2021-02-16
Option Award
2022-02-14
4:13 pm
N/A
2031-02-15
GT Biopharma Inc. GTBP SHROTRIYA RAJESH C MD
Director
50,000 $0 50,000
(Direct)
View
2021-12-31
Option Award
2022-02-14
4:09 pm
N/A
2031-12-31
GT Biopharma Inc. GTBP Choy Gavin
CFO
227,500 $0 227,500
(Direct)
View
2021-02-16
Conversion
2021-11-12
12:01 pm
N/A
N/A
GT Biopharma Inc. GTBP Breen Michael Martin
Director
50,102 $3.4 378,160
(Direct)
View
2021-02-16
Option Award
2021-11-12
12:01 pm
N/A
2031-02-15
GT Biopharma Inc. GTBP Breen Michael Martin
Director
328,058 $0 378,160
(Direct)
View
2021-02-16
Conversion
2021-11-12
12:01 pm
2018-09-07
N/A
GT Biopharma Inc. GTBP Breen Michael Martin
Director
130,000 $0 378,160
(Direct)
View
2021-01-13
Ownership
2021-11-12
12:01 pm
2018-09-07
N/A
GT Biopharma Inc. GTBP Breen Michael Martin
Director
0 $0 0
(Direct)
View
2020-11-16
Option Award
2021-10-07
2:47 pm
N/A
2031-02-15
GT Biopharma Inc. GTBP Wendel Bruce
Director
397,572 $0 402,655
(Direct)
View
2019-08-14
Option Award
2019-08-16
4:57 pm
N/A
N/A
GT Biopharma Inc. GTBP Cataldo Tony
CEO
10% Owner
7,000,000 $0 10,734,320
(Direct)
View
2019-08-14
Option Award
2019-08-16
4:51 pm
N/A
N/A
GT Biopharma Inc. GTBP Weldon Steven W
CFO
10% Owner
4,500,000 $0 6,769,707
(Direct)
View
2017-09-01
Gift
2017-12-01
7:12 pm
N/A
N/A
GT Biopharma Inc. GTBP Cataldo Tony
Chairman
10% Owner
3,300,000 $0 1,843,029
(Direct)
View
2017-09-01
Option Award
2017-12-01
7:12 pm
N/A
N/A
GT Biopharma Inc. GTBP Cataldo Tony
Chairman
10% Owner
5,129,660 $0 1,843,029
(Direct)
View
2017-09-01
Ownership
2017-12-01
5:35 pm
N/A
N/A
GT Biopharma Inc. GTBP Urbanski Raymond W.
Chief Medical Officer
0 $0 1,528,989
(Direct)
View
2017-09-01
Ownership
2017-12-01
5:25 pm
N/A
N/A
GT Biopharma Inc. GTBP Clarence-Smith Kathleen
CEO
10% Owner
0 $0 8,505,633
(Direct)
View
2017-09-01
Option Award
2017-12-01
5:17 pm
N/A
N/A
GT Biopharma Inc. GTBP Weldon Steven W
CFO
2,566,835 $0 2,568,840
(Direct)
View
2017-09-01
Ownership
2017-12-01
5:06 pm
N/A
N/A
GT Biopharma Inc. GTBP Silverman Mark J
10% Owner
0 $0 8,172,079
(Direct)
View